United Kingdom· GB-APID-39850211000001107
AdreView [I-123] 111MBq/1.5ml solution for injection vials
A medicinal product containing iobenguane [i-123], registered in United Kingdom by GE Healthcare Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Iobenguane [I-123]
- Manufacturer
- GE Healthcare Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Iobenguane [i-123] in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAdreView Iobenguane (I-123)
- BelgiumAdreview 74 MBq/mlGE Healthcare
- NetherlandsAdreView, Iobenguane (123I) Injection, oplossing voor injectie 74 MBq/mlGE Healthcare B.V.
- GermanyAdreviewGe Healthcare Buchler Gmbh & Co. Kg
- PolandMetajodobenzyloguanidyna- 123 I (MIBG-123 I)Narodowe Centrum Badań Jądrowych
- United StatesAdreViewMedi-Physics Inc.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Adreview, Mibg (123i)
- Czechia · Mibg (I123) Curium Netherlands
- Germany · Adreview
- Denmark · Adreview, Mibg (123i) Curium Netherlands
- Spain · Adreview, Mibg (123i) Curium Pharma Spain
- France · Adreview (123i), Mibg (123i) Curium Netherlands
- Hungary · [123i]-Mibg, [123i]-Mibg Curium Netherlands
- Ireland · Mibg (123i) Curium Netherlands
- Italy · [123i]-Mibg, Adreview
- Luxembourg · Adreview
- Netherlands · Adreview, Mibg (I123) Jobenguaan Curium Netherlands
- Norway · Adreview
- Slovakia · 123i Mibg Inj
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e022ac29-f8e0-4deb-bede-4c4e035b773c GET /v1/drugs/e022ac29-f8e0-4deb-bede-4c4e035b773c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39850211000001107",
"desc": "AdreView [I-123] 111MBq/1.5ml solution for injection vials (GE Healthcare Ltd)",
"form": "Solution for injection",
"vpid": "39909411000001103",
"source": "dmd",
"vtm_id": "42779511000001109",
"strength": "74 MBq",
"substance": "Iobenguane [I-123]",
"ingredient": "Iobenguane [I-123]",
"supplier_code": "11269611000001107"
}See everything about iobenguane [i-123].
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.